M&ABone Therapeutics merges with Medsenic and...Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a €40m deal and changed its name into BioSenic. more ➔
financingResolve Biosciences secures US$71m in fund...Molecular cartography company Resolve Biosciences has raised $71m in series B funding co-led by Patient Square Capital, EDBI, Alafi Capital and NRW.BANK as well as other existing investors. more ➔
financingEnhanc3D Genomics raises £10m in Series A...Cambridge-based Enhanc3D Genomics Ltd has raised £10m in Series A financing led by BGF and Parkwalk Advisors. more ➔
financingUnivercells SA raises €44m in first clos...Belgian CDMO Univercells SA has raised €44m through the first close of its Series D financing round led by Belgian and international investors. I more ➔
SepsisAdrenomed set to start pivotal trial in se...German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study. more ➔
financingMablink raises $31m in Series A financingMablink Bioscience has baged €31m in a Series A round led by Sofinnova Partners and Mérieux Equity Partners to speed up its pipeline of ADCs. more ➔
Industria Experts showcase next-gen biotech solution...Industry experts have presented the latest biotech solutions for tackling climate change at the first INDUSTRIA BIOTEC conference, Europe’s new forum for the industrial biotech sector. more ➔
partnerStalicla SA and Evgen Pharma plc ink $160....Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia. more ➔
Clinical Microbiomics A/S bags €10m fina...Danish microbiome specialist Clinical Microbiomics A/S has completed a €10m growth financing led by – Seventure Partners. more ➔
EU starts largest study on factors affecti...The EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence. more ➔
